Company Search:
Advanced Search
Sponsored Links
Choong Ang Vaccine Laboratory Company Snapshot
Choong Ang Vaccine Laboratory operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Choong Ang Vaccine Laboratory with three other companies in this sector in South Korea: Komipharm International Company Limited (2015 sales of 36.41 billion Korean Won [US$32.66 million] of which 100% was Animal Pharmaceutical), Corestem Inc (18.57 billion Korean Won [US$16.66 million] of which 78% was The clinical trial agent), and Cell Biotech Co ., Limited. (49.50 billion Korean Won [US$44.41 million] of which 84% was Finished Products).

Sales Analysis. During the year ended December of 2015, sales at Choong Ang Vaccine Laboratory were 34.60 billion Korean Won (US$31.04 million). This is an increase of 16.9% versus 2014, when the company's sales were 29.61 billion Korean Won. This was the fourth straight year of sales growth at Choong Ang Vaccine Laboratory.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Choong Ang Vaccine Laboratory
  Stock Performance Chart for Choong Ang Vaccine Laboratory
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 19,000
(Figures in Korean Won)
1 Week -1.8%   13 Weeks -10.4%  
4 Weeks -24.9%   52 Weeks 13.8%  
Choong Ang Vaccine Laboratory Key Data:
  Ticker: 072020 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 34,604,971,506
(Year Ending Jan 2016).
Employees: 138
  Currency: Korean Won Market Cap: 139,080,000,000
  Fiscal Yr Ends: December Shares Outstanding: 7,320,000
  Share Type: Common Closely Held Shares: 3,125,346
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.